Icra sees pharma industry growth tapering to 7-10% over FY18-FY20Post published:July 4, 2017Post category:Industry NewsThe Indian pharma industry is likely to witness a slowdown in growth because of pricing pressure and regulatory interventions in the US, according to an Icra report Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostIndoStar Capital close to acquiring ICICI Home Finance Next PostGST rates: Footwear to cost more as firms look to increase prices by 5-7% You Might Also Like SBI, associate banks merger: Share swap record date set as 17 March March 3, 2017 Chucks of Choice: pullback-style chucks for OP 10 to OP 30 turning October 17, 2017 Digitalization and the Food and Beverage Industry January 10, 2019